Tearsheet

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 23%
Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 59x
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 30%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 27%
Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.5%
2 Low stock price volatility
Vol 12M is 37%
Key risks
WAY key risks include [1] its dependency on third parties for critical functions such as its claims management suite, Show more.
3 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine, and Cloud Computing. Themes include Health Data Analytics, AI in Healthcare Management, Show more.
 
0 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 23%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 30%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 27%
2 Low stock price volatility
Vol 12M is 37%
3 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine, and Cloud Computing. Themes include Health Data Analytics, AI in Healthcare Management, Show more.
4 Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 59x
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.5%
6 Key risks
WAY key risks include [1] its dependency on third parties for critical functions such as its claims management suite, Show more.

Valuation, Metrics & Events

WAY Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Waystar (WAY) experienced a -14.8% stock movement between August 31, 2025, and December 18, 2025, driven by several key factors:

1. Significant Insider Selling Activity: A notable event contributing to negative sentiment was the sale of 4,295,139 shares by Director Paul G. Moskowitz on September 12, 2025, totaling approximately $168.4 million. This substantial insider transaction likely signaled a lack of confidence to investors, contributing to downward pressure on the stock.

2. Broader Market Caution and Q4 Volatility: The general market environment during the fourth quarter of 2025 was characterized by concerns regarding interest rates, inflationary pressures, and market concentration. This led to increased volatility and a cautious approach from investors across the market, which could have dampened Waystar's stock performance despite company-specific positive developments.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
WAY Return-10%
Peers Return44%-8%-34%-33%20%-29%-50%
S&P 500 Return16%27%-19%24%23%14%108%

Monthly Win Rates [3]
WAY Win Rate100%58% 
Peers Win Rate69%44%36%47%53%25% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
WAY Max Drawdown-17% 
Peers Max Drawdown-40%-14%-54%-54%-32%-38% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: PHR, TBRG, HCAT.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/17/2025 (YTD)

How Low Can It Go

WAY has limited trading history. Below is the Health Care sector ETF (XLV) in its place.

Unique KeyEventXLVS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-16.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven19.1%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven599 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-28.8%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven40.4%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven116 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-15.8%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven18.8%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven326 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-40.6%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven68.3%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1,100 days1,480 days

Compare to


In The Past

SPDR Select Sector Fund's stock fell -16.1% during the 2022 Inflation Shock from a high on 4/8/2022. A -16.1% loss requires a 19.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Waystar (WAY)

Better Bets than Waystar (WAY)

Trade Ideas

Select past ideas related to WAY. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.8%16.8%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-6.4%-6.4%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
5.2%5.2%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.4%3.4%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
14.4%14.4%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.8%16.8%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-6.4%-6.4%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
5.2%5.2%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.4%3.4%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
14.4%14.4%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Waystar

Peers to compare with:

Financials

WAYPHRTBRGHCATMedian
NameWaystar Phreesia TruBridgeHealth C. 
Mkt Price32.2716.3022.092.3919.20
Mkt Cap5.61.40.30.20.9
Rev LTM1,040463347316405
Op Inc LTM243-922-647
FCF LTM2853521-3328
FCF 3Y Avg--151-31-15
CFO LTM3086138-1350
CFO 3Y Avg-1021-1410

Growth & Margins

WAYPHRTBRGHCATMedian
NameWaystar Phreesia TruBridgeHealth C. 
Rev Chg LTM14.8%14.3%3.1%4.6%9.5%
Rev Chg 3Y Avg-21.0%3.1%5.2%5.2%
Rev Chg Q11.9%12.7%1.7%-0.0%6.8%
QoQ Delta Rev Chg LTM2.8%3.0%0.4%-0.0%1.6%
Op Mgn LTM23.4%-1.9%6.5%-20.1%2.3%
Op Mgn 3Y Avg--21.7%1.8%-31.1%-21.7%
QoQ Delta Op Mgn LTM2.6%4.0%0.3%-1.2%1.5%
CFO/Rev LTM29.6%13.3%11.1%-4.0%12.2%
CFO/Rev 3Y Avg-1.0%6.2%-4.8%1.0%
FCF/Rev LTM27.4%7.6%6.0%-10.6%6.8%
FCF/Rev 3Y Avg--5.3%0.2%-10.4%-5.3%

Valuation

WAYPHRTBRGHCATMedian
NameWaystar Phreesia TruBridgeHealth C. 
Mkt Cap5.61.40.30.20.9
P/S6.43.00.80.51.9
P/EBIT27.2---2.112.5
P/E59.5-262.481.6-1.629.0
P/CFO21.523.07.6-13.214.6
Total Yield1.7%-0.4%1.2%-64.0%0.4%
Dividend Yield0.0%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg----9.2%-9.2%
D/E0.2--1.00.6
Net D/E0.1--0.50.3

Returns

WAYPHRTBRGHCATMedian
NameWaystar Phreesia TruBridgeHealth C. 
1M Rtn-5.9%-20.9%7.7%6.7%0.4%
3M Rtn-16.4%-30.0%6.0%-14.9%-15.7%
6M Rtn-15.0%-36.5%-4.0%-34.5%-24.8%
12M Rtn-9.1%-34.4%22.1%-68.8%-21.8%
3Y Rtn--52.0%-16.4%-77.8%-52.0%
1M Excs Rtn-6.6%-21.6%7.0%6.0%-0.3%
3M Excs Rtn-17.7%-34.0%1.8%-22.2%-20.0%
6M Excs Rtn-27.4%-48.9%-16.3%-46.9%-37.2%
12M Excs Rtn-16.4%-45.7%9.2%-81.2%-31.0%
3Y Excs Rtn--117.9%-88.3%-145.9%-117.9%

Financials

Segment Financials

Revenue by Segment

$ Mil202420232022
Single Segment791  
Implementation services and other revenue 32
Subscription revenue 367334
Volume-based revenue 335242
Total791705579


Price Behavior

Short Interest

Short Interest: As Of Date11282025
Short Interest: Shares Quantity8,453,409
Short Interest: % Change Since 111520250.6%
Average Daily Volume1,390,243
Days-to-Cover Short Interest6.08
Basic Shares Quantity174,352,079
Short % of Basic Shares4.8%

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
10/29/2025-6.5%-7.2%-8.3%
7/23/20250.1%-3.6%-3.3%
4/30/20256.2%10.4%7.6%
2/18/2025-0.5%-7.2%-18.6%
11/6/20247.7%4.7%5.0%
8/7/202410.5%14.4%26.7%
SUMMARY STATS   
# Positive433
# Negative233
Median Positive6.9%10.4%7.6%
Median Negative-3.5%-7.2%-8.3%
Max Positive10.5%14.4%26.7%
Max Negative-6.5%-7.2%-18.6%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251029202510-Q 9/30/2025
6302025730202510-Q 6/30/2025
3312025430202510-Q 3/31/2025
12312024218202510-K 12/31/2024
93020241106202410-Q 9/30/2024
6302024807202410-Q 6/30/2024
123120236072024424B4 12/31/2023
1231202210162023S-1 12/31/2022